Figure 1 Dysregulations of the BBB reduce blood flow and permit entry to the brain of toxic molecules, immune cells, and microbial agents (Kisler et al., 2017)
REIMAGINE 2 was a 68-week efficacy & safety trial investigating once weekly SC CagriSema, a fixed-dose combination of the Amylin receptor agonist, cagrilintide, & GLP-1RA, Semaglutide, compared to Semaglutide & placebo, the study enrolled 2,728 patients with type 2 diabetes inadequately controlled with metformin with or without an SGLT2I
Glucagon-like peptide-1 analogs: miracle drugs are blooming
Occasional mild changes arent always dangerous, especially if they resolve quickly
A general dietary pattern to lower triglycerides is the Mediterranean diet
#healthandwellness #biohacking #peptide #looksmaxing #antiagingtips Replying to @Lindsay Ive noticed a huge difference with the NAD